arrow
返回期刊详情
Lancet Haematology 封面图

Lancet Haematology

IF17.7
论文数1839
被引数7818
期刊论文 1839
发表时间
Future-proofing thalassaemia care: harnessing scalable therapies, artificial intelligence, and global collaboration为地中海贫血护理的未来做准备:利用可扩展疗法、人工智能和全球合作
delete2026-10-06
delete0
PREAI
deleteHanny Al-Samkari; Fouzia Aboobacker; Biree Andemariam; Perla Eleftheriou; Hatoon Ezzat; Dimitrios Farmakis; Shahrukh Hashmi; Shruti Kakkar; Aurelio Maggio; Antonio Piga; Alok Srivastava; Mohamed A Yassin; Hasan Abbas Zaheer; Vip Viprakasit; Khaled M Musallam
delete分享
delete收藏
MK-4002, a B-cell maturation antigen-targeting T-cell engager, in relapsed or refractory multiple myeloma: a first-in-human, open-label, phase 1 studyMK-4002,一种靶向B细胞成熟抗原的T细胞接合剂,在复发或难治性多发性骨髓瘤中的应用:一项首次人体、开放标签的1期研究
delete2026-10-06
delete0
PREAI
deleteSumit Madan; Caitlin Costello; Brea Lipe; Andrew J Cowan; Eva Medvedova; Jens Hillengass; P Leif Bergsagel; Xavier Leleu; Cyrille Touzeau; Daniel Morillo; Albert Oriol; Raya Mawad; Henning Schade; Yifah Yaron; Patrick P Ng; Banmeet Anand; Razia Akhtar; Al-Ola Abdallah
delete分享
delete收藏
Rethinking the possibilities of adult ring sideroblastic anaemia重新思考成人环状铁粒幼细胞贫血的可能性
delete2026-10-06
delete0
PREAI
deleteSophie G Carlson; Matthew Koo; Sunil Dommaraju; Alexander H Song; Wanxing Chai-Ho
delete分享
delete收藏
Clinical activity and safety of rilzabrutinib in patients with previously treated immune thrombocytopenia (LUNA3): results from the open-label period of a phase 3 trial利扎布鲁替尼在既往治疗过的免疫性血小板减少症患者中的临床活性和安全性(LUNA3):一项III期试验开放标签期的结果
delete2026-09-17
delete0
PREAI
deleteDavid J Kuter; Waleed Ghanima; Nichola Cooper; Howard A Liebman; Lei Zhang; Yu Hu; Yoshitaka Miyakawa; Marie Luise Hütter-Krönke; Cristina Pascual-Izquierdo; Elisa Lucchini; Sylvain Audia; Matias Cordoba; Heidi Krenz; Mengjie Yao; Ahmed Daak
delete分享
delete收藏
Topical ruxolitinib for chronic cutaneous graft-versus-host disease: a single-centre, randomised, double-blind, intra-patient-controlled phase 2 trial鲁索利替尼外用制剂治疗慢性皮肤移植物抗宿主病:一项单中心、随机、双盲、患者内对照的2期临床试验
delete2026-09-16
delete0
deleteOAAI
deleteAlina Markova; Jelena Ostojić; Veronica Rotemberg; Ian Nykaza; Jad Kanbar; Esperanza B Papadopoulos; Stephen Dusza; Rizi Ai; Tara Maier; Mario E Lacouture; Roni Tamari; Brian C Shaffer; Michael Scordo; Miguel-Angel Perales; Andrew Harris; Doris M Ponce
delete分享
delete收藏
High time for risk-adapted treatment in mantle cell lymphoma套细胞淋巴瘤中风险适应治疗的适时性
delete2026-09-02
delete0
PREAI
deleteIngrid Glimelius; Anna Nikkarinen; Leo Meriranta; Simon Husby; Christiane Pott
delete分享
delete收藏
Epcoritamab with rituximab and lenalidomide as first-line treatment for follicular lymphoma (EPCORE NHL-2): an open-label, multicentre, phase 1/2 b trialEpcoritamab联合利妥昔单抗和来那度胺作为滤泡性淋巴瘤的一线治疗(EPCORE NHL-2):一项开放标签、多中心、1/2b期临床试验
delete2026-08-27
delete0
deleteOAAI
deleteLorenzo Falchi; Joost S P Vermaat; Joshua D Brody; Lori Leslie; Fritz Offner; Jacob Haaber Christensen; Marcel Nijland; David Belada; Björn Engelbrekt Wahlin; Kristina Drott; Pilar Gomez Prieto; Kateřina Kopečkova; Alejandro Martín García-Sancho; Jian P Mei; Işıl Altıntaş; Malene Risum; Aidan Reilly; Jun Zou; Pau Abrisqueta
delete分享
delete收藏